G-DOC: A systems medicine platform for personalized oncology

Neoplasia

Volumn 13, Issue 9, 2011, Pages 771-783

  Madhavan, Subha ^a   Gusev, Yuriy ^b   Harris, Michael ^b   Tanenbaum, David M ^c   Gauba, Robinder ^a   Bhuvaneshwar, Krithika ^a   Shinohara, Andrew ^c   Rosso, Kevin ^c   Carabet, Lavinia A ^a   Song, Lei ^a   Riggins, Rebecca B ^a   Dakshanamurthy, Sivanesan ^a   Wang, Yue ^a   Byers, Stephen W ^a   Clarke, Robert ^a   Weiner, Louis M ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b ESAC Inc   (United States)

^c Virginia Polytechnic Institute and State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; MICRORNA;

ACCESS TO INFORMATION; ARTICLE; BREAST CANCER; CANCER RESEARCH; CLINICAL DATA REPOSITORY; COMPUTER INTERFACE; COMPUTER PROGRAM; COMPUTER SYSTEM; DATA COLLECTION METHOD; DIGESTIVE SYSTEM CANCER; FACTUAL DATABASE; GENE DOSAGE; GENE EXPRESSION; GENOMICS; MEDICAL INFORMATION SYSTEM; METABOLOMICS; MOLECULAR BIOLOGY; ONCOLOGY; PERSONALIZED MEDICINE; PRIORITY JOURNAL; SYSTEMS BIOLOGY;

EID: 80053438182     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.11806     Document Type: Article

References (49)

1. Butte AJ (2008). Translational bioinformatics: coming of age. J Am Med Inform Assoc 15(6), 709-714.
2. Sarkar IN, Butte AJ, Lussier YA, Tarczy-Hornoch P, and Ohno-Machado L (2011). Translational bioinformatics: linking knowledge across biological and clinical realms. J Am Med Inform Assoc 18(4), 354-357.
3. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al. (2004). Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5(10), R80.
4. Calin GA and Croce CM (2006). MicroRNA signatures in human cancers. Nat Rev Cancer 6, 857-866.
5. Hennessy E and O'Driscoll L (2008). Molecular medicine of microRNAs: structure, function and implications for diabetes. Expert Rev Mol Med 10, e24.
6. Callis TEE and Wang D-ZZ (2008). Taking microRNAs to heart. Trends Mol Med 14, 254-260.
7. Uchida S, Nishida A, Hara K, Kamemoto T, Suetsugi M, Fujimoto M, Watanuki T, Wakabayashi Y, Otsuki K, McEwen BS, et al. (2008). Characterization of the vulnerability to repeated stress in Fischer 344 rats: possible involvement of microRNA-mediated down-regulation of the glucocorticoid receptor. Eur J Neurosci 27, 2250-2261.
8. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, and Enright AJ (2006). Mirbase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34, D140-D144.
9. Friedman RC, Farh KK, Burge CB, and Bartel DP (2009). Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19, 92-105.
10. Brase J, Wuttig D, Kuner R, and Sultmann H (2010). Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer 9, 306.
11. Huang Z, Huang D, Ni S, Peng Z, Sheng W, and Du X (2010). Plasma micro-RNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127(1), 118-126.
12. Availablet at: http://www.docstoc.com/docs/10956998/The-NIH-Roadmap-to-Understanding-Biological-Pathways-and-Networks-with-Metabolomics. Accessed June 1, 2011.
13. Kuo K-TT, Guan B, Feng Y, Mao T-LL, Chen X, Jinawath N, Wang Y, Kurman RJ, Shih IeM, and Wang T-LL (2009). Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas. Cancer Res 69(12), 5267.
14. Saldanha AJ (2004). Java TreeView-extensible visualization of microarray data. Bioinformatics 20(17), 3246-3248.
15. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, and Ideker T (2003). Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11), 2498-2504.
16. Skinner ME, Uzilov AV, Stein LD, Mungall CJ, and Holmes IH (2009). JBrowse: a next-generation genome browser. Genome Res 19(9), 1630-1638.
17. Barrett T, Suzek TO, Troup DB, Wilhite SE, Ngau W-CC, Ledoux P, Rudnev D, Lash AE, Fujibuchi W, and Edgar R (2005). NCBI GEO: mining millions of expression profiles-database and tools. Nucleic Acids Res 33, D562-D566.
18. Parkinson H, Sarkans U, Shojatalab M, Abeygunawardena N, Contrino S, Coulson R, Farne A, Lara GG, Holloway E, Kapushesky M, et al. (2005). ArrayExpress-a public repository for microarray gene expression data at the EBI. Nucleic Acids Res 33, D553-D555.
19. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, and Speed TP (2003). Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31(4), e15.
20. Bolstad BM, Irizarry RA, Astrand M, and Speed TP (2003). A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19(2), 185-193.
21. Wright GW and Simon RM (2003). A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19, 2448-2455.
22. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, et al. (2007). MicroRNA signatures in human ovarian cancer. Cancer Res 67, 8699-8707.
23. Livak KJ and Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4), 402-408.
24. Schmittgen TD, Lee EJJ, Jiang J, Sarkar A, Yang L, Elton TS, and Chen C (2008). Real-time PCR quantification of precursor and mature microRNA. Methods 44(1), 31-38.
25. Kozomara A and Griffiths-Jones S (2011). Mirbase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res, D152-D157.
26. Pedrioli PGA, Eng JK, Hubley R, Vogelzang M, Deutsch EW, Raught B, Pratt B, Nilsson E, Angeletti RH, Apweiler R, et al. (2004). A common open representation of mass spectrometry data and its application to proteomics research. Nat Biotech 22, 1459-1466.
27. Li C and Wong WH(2003). DNA-chip analyzer (dChip). In The Analysis of Gene Expression Data: Methods and Software. G Parmigiani, ES Garrett, R Irizarry, and SL Zeger (Eds). Springer, New York, NY. pp. 120-141.
28. Feng Y, Yu G, Wang T-L, Shih I-M, and Wang Y (2010). AnalyzingDNA copy number changes using fused margin regression. Intl J Funct Inform Pers Med 3(1), 3-15.
29. Loi S, Haibe-Kains B, Desmedt C, Wirapati P, Lallemand F, Tutt AM, Gillet C, Ellis P, Ryder K, Reid JF, et al. (2008). Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen. BMC Genomics 9, 239.
30. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, Nordgren H, Farmer P, Praz V, Haibe-Kains B, et al. (2006). Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 98(4), 262-272.
31. Raychaudhuri S, Stuart JM, and Altman RB (2000). Principal components analysis to summarize microarray experiments: application to sporulation time series. Pac Symp Biocomput, 455-466.
32. Golay J, Loffarelli L, Luppi M, Castellano M, and Introna M (1994). The human A-myb protein is a strong activator of transcription. Oncogene 9(9), 2469-2479.
33. Kaplan EL and Meier P (1958). Nonparametric estimation from incomplete observations. J Am Stat Assoc 53, 457-481.
34. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P, et al. (2011). The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39, D561-D568.
35. Rebhan M, Chalifa-Caspi V, Prilusky J, and Lancet D (1997). GeneCards: integrating information about genes, proteins and diseases. Trends Genet 13(4), 163.
36. Wu CH, Huang H, Arminski L, Castro-Alvear J, Chen Y, Hu ZZ, Ledley RS, Lewis KC, Mewes HW, Orcutt BC, et al. (2002). The Protein Information Resource: an integrated public resource of functional annotation of proteins. Nucleic Acids Res 30(1), 35-37.
37. Online Mendelian Inheritance in Man (OMIM). McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore,MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda,MD). Availablet at: http://www.ncbi.nlm.nih.gov/omim/. Accessed June 1, 2011.
38. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, and Sirotkin K (2001). Dbsnp: the NCBI database of genetic variation. Nucleic Acids Res 29(1), 308-311.
39. Sircoulomb F, Bekhouche I, Finetti P, Adelaide J, Hamida AB, Bonansea J, Raynaud S, Innocenti C, Charafe-Jauffret E, Tarpin C, et al. (2010). Genome profiling of ERBB2-amplified breast cancers. BMC Cancer 10, 539.
40. Chuang H-YY, Lee E, Liu Y-TT, Lee D, and Ideker T (2007). Network-based classification of breast cancer metastasis. Mol Syst Biol 3, 140.
41. Reymond MA and Schlegel W (2007). Proteomics in cancer. Adv Clin Chem 44, 103-142.
42. Chin L and Gray JW (2008). Translating insights from the cancer genome into clinical practice. Nature 452, 553-563.
43. Roukos DH (2010). Systems medicine: a real approach for future personalized oncology? Pharmacogenomics 11(3), 283-287.
44. Madhavan S, Zenklusen J-C, Kotliarov Y, Sahni H, Fine HA, and Buetow K (2009). Rembrandt: helping personalized medicine become a reality through integrative translational research. Mol Cancer Res 7(2), 157-167.
45. Weston AD and Hood L (2004). Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. J Proteome Res 3(2), 179-196.
46. Auffray C, Chen Z, and Hood L (2009). Systems medicine: the future of medical genomics and healthcare. Genome Med 1(1), 2.
47. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, and Chinnaiyan AM (2004). ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6(1), 1-6.
48. Sherlock G, Hernandez-Boussard T, Kasarskis A, Binkley G, Matese JC, Dwight SS, Kaloper M, Weng S, Jin H, Ball CA, et al. (2001). The Stanford Microarray Database. Nucleic Acids Res 29(1), 152-155.
49. Madhavan S, Sander A, Chou W-Y, Shuster A, Boone K, Dente M, Shad A, and Hesse B (2011). Pediatric palliative care in the age of eHealth: opportunities for advances in HIT to improve patient-centered communication. Am J Prev Med 40(5 suppl 2), S208-S216.